Menu
/REGISTER
Montecito
Citizens
QQQ
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  -  Page 60

Montecito Bank & Trust
Latest

Deckers Brands sales up 20 percent year-over-year

By   /  Thursday, July 27th, 2017  /  Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Deckers Brands sales up 20 percent year-over-year

Deckers Brands reported a 20.3 percent year-over-year net increase in sales but still had a net loss of $42.1 million for its fiscal first quarter ended June 30. Sales continued to grow in its direct-to-consumer channel, including its Hoka One One brand, and the figure included wholesale shipments of Ugg products originally expected to ship Read More →

Read More →
Latest

MindBody revenues up but net losses continue

By   /  Wednesday, July 26th, 2017  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MindBody revenues up but net losses continue

Consistent with its last earnings report, MindBody’s revenues increased 31 percent for its second fiscal quarter 2017, but net losses persisted, reaching $4.4 million, or 10 cents per basic and diluted share. The San Luis Obispo-based software provider for the wellness industry brought in $44.1 million in revenue, including $17.6 million from its payments software. Read More →

Read More →
Latest

Goleta medical device maker stocks are hot

By   /  Friday, July 21st, 2017  /  Earnings, Health Care, Latest news, South Coast, Technology, Tri-County Public Companies  /  Comments Off on Goleta medical device maker stocks are hot

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen partnering to develop new drugs

By   /  Friday, July 21st, 2017  /  East Ventura County, Health Care, Latest news, Tri-County Public Companies  /  Comments Off on Amgen partnering to develop new drugs

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen’s Kyprolis found to increase cancer survival rate

By   /  Thursday, July 13th, 2017  /  East Ventura County, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen’s Kyprolis found to increase cancer survival rate

A Phase 3 clinical study of Amgen’s multiple myeloma drug Kyprolis showed that it increased overall survival rate when paired with lenalidomide and dexamethasone versus just those two drugs alone. The drug reduced the risk of death by 21 percent, and patients lived 7.9 months longer when on a regimen that included Kyprolis than those Read More →

Read More →
Latest

Frontier Communications completes 1-for-15 reverse stock split

By   /  Monday, July 10th, 2017  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Frontier Communications completes 1-for-15 reverse stock split

Frontier Communications completed a 1-for-15 reverse stock split on July 10, opening at $16.35 per share, with around 175 million shares outstanding. The company announced the split March 28 when it filed paperwork with the Securities and Exchange Commission, and the move was approved by shareholders and the board of directors May 10. Its market Read More →

Read More →
Latest

Sienna Biopharmaceuticals files for $75 million IPO

By   /  Thursday, July 6th, 2017  /  East Ventura County, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Sienna Biopharmaceuticals files for $75 million IPO

Westlake Village biotechnology company Sienna Biopharmaceuticals filed for an initial public offering with the Securities and Exchange Commission on June 3, stating expectations to raise up to $74.75 million. Founded in 2010, the company develops clinical-stage topical therapies for inflammatory skin diseases and other conditions. ARCH Venture Partners and Venvest Capital led a $40 million Read More →

Read More →